Inositol for PCOS: Myo-Inositol vs D-Chiro-Inositol

Myo-inositol is one specific form of inositol, not a different supplement: inositol is the family name for nine related molecules, and myo-inositol is the most abundant of them in the body and the one most bottles labeled simply "inositol" contain. For polycystic ovary syndrome (PCOS), the most studied regimen is 4 grams of myo-inositol per day, often paired with D-chiro-inositol in a 40:1 ratio, while the 2023 International PCOS Guideline from Monash University concluded the evidence is too limited to recommend any specific type or dose.

Inositol may help some women with PCOS by improving how the body responds to insulin, which in turn can support more regular ovulation. The evidence is promising but still limited, so inositol is best seen as a reasonable, low-risk option to discuss with your clinician rather than a sure fix.

What inositol is and why it matters in PCOS

Inositol is a naturally occurring compound found in foods such as fruits, beans, grains, and nuts, and your body also makes it. It acts as a messenger inside cells, helping relay the signal from insulin so that glucose can be used properly. This is relevant to PCOS because insulin resistance is a common feature of the condition. When cells respond poorly to insulin, the body produces more of it, and higher insulin levels can drive the ovaries to make more androgens (male-type hormones). That hormonal shift is part of what disrupts ovulation and contributes to irregular cycles, acne, and unwanted hair growth.

The thinking behind inositol supplementation is straightforward: if some of the difficulty in PCOS comes from impaired insulin signaling, then supplying more of the inositol messengers might help restore that signaling and ease the downstream hormonal effects. For a broader overview of the condition, see our complete guide to PCOS.

Inositol is sometimes called vitamin B8, though it is not a true vitamin because the body makes its own supply. Inside cells, inositol is built into signaling molecules called inositol phosphoglycans, which act as second messengers for insulin and for follicle-stimulating hormone (FSH) in the ovary. That dual role is why researchers study it for both the metabolic side of PCOS and the reproductive side.

Inositol vs myo-inositol: are they the same thing?

Inositol and myo-inositol are not two competing supplements. Inositol is the umbrella name for a family of nine stereoisomers, molecules with the same atoms arranged in different shapes, and myo-inositol is the most common member of that family in food and in human tissue. A supplement labeled only "inositol" almost always contains myo-inositol, sometimes listed as "inositol (as myo-inositol)."

The practical difference for a reader comparing labels is what else is in the bottle. A plain inositol or myo-inositol product supplies MI alone. A product marketed for PCOS may add D-chiro-inositol, usually in a 40:1 ratio, and often folic acid. Another product, inositol hexaphosphate (IP6, also called phytic acid), is a different compound studied for other purposes, and it is not the form used in the PCOS trials.

Myo-inositol vs D-chiro-inositol

There are nine forms of inositol, but two matter most in PCOS research.

• Myo-inositol (MI) is the most abundant form in the body. In the ovary it supports glucose uptake and is involved in the signaling needed for healthy egg (oocyte) development and ovulation.
• D-chiro-inositol (DCI) is made from myo-inositol by an insulin-dependent enzyme. It is more involved in glycogen synthesis and storage. Different tissues maintain different ratios of the two forms depending on their needs.

The key insight from research is that balance matters. Tissues that handle a lot of glucose storage tend to hold more DCI, while the ovary is myo-inositol rich. Some studies suggest that women with PCOS may have an altered conversion between the two forms in the ovary, which is sometimes described as the “DCI paradox.” The practical takeaway is that more D-chiro-inositol is not better, and excess DCI may actually work against egg quality and ovulation.

What is the DCI paradox?

The DCI paradox describes a mismatch in how PCOS appears to affect different tissues. In muscle and fat, insulin resistance may slow the conversion of MI into DCI, while the ovary, which stays sensitive to insulin, may convert too much MI into DCI. The result is an ovary that can run low on the myo-inositol it needs for FSH signaling and egg development. This idea, developed largely by Italian research groups including Vittorio Unfer and colleagues, is still a working hypothesis.

The 40:1 ratio explained

The 40:1 figure refers to the ratio of myo-inositol to D-chiro-inositol that mirrors the proportion normally found in human blood plasma. A frequently cited trial published in European Review for Medical and Pharmacological Sciences (Nordio and colleagues, 2019) compared several different MI/DCI ratios in women with PCOS over three months. The 40:1 ratio performed best for restoring ovulation and improving metabolic and hormonal markers, and the benefit decreased as the formula was shifted in favor of more DCI.

A few points are worth holding in mind. This was a small study, with groups of only about eight women each, so it should be read as supportive rather than definitive. It is also worth noting that the plasma ratio is 40:1, while the ratio inside the ovarian follicle is closer to 100:1, so the 40:1 number is a practical reference point rather than a perfectly settled biological target. Even so, 40:1 has become the most common ratio in commercial PCOS inositol products precisely because of this line of research.

What the evidence shows for ovulation and insulin

Across a number of randomized controlled trials and meta-analyses, myo-inositol (often at 4 grams per day) has been associated with improvements in insulin sensitivity, more regular menstrual cycles, and modest reductions in androgen levels in some women with PCOS. Several trials and pooled analyses have found that myo-inositol and metformin produce broadly similar effects on measures such as ovulation and pregnancy rates, with inositol tending to be better tolerated. If you are weighing those two options, our comparison of metformin versus inositol for PCOS goes into more detail.

It is important to be honest about the limits of this evidence. The 2023 International Evidence-based Guideline for the Assessment and Management of PCOS, developed with input from ESHRE, ASRM, and Monash University, concluded that specific types, doses, or combinations of inositol cannot currently be recommended in adults or adolescents with PCOS because of a lack of high-quality evidence. The guideline group acknowledged that inositol is low-risk and that some women may still choose to try it, and they framed it as a shared decision to make with a clinician. In other words, the signal is encouraging and the safety profile is reassuring, but the research base is not yet strong or consistent enough for inositol to be a formal recommendation.

What did the 2023 PCOS guideline say about inositol?

The 2023 International Evidence-based Guideline for PCOS, led by Monash University with the European Society of Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM), treats inositol as an evidence-limited option. It found that inositol in any form may offer some metabolic benefit but limited clinical benefit for ovulation, hirsutism or weight. The guideline describes inositol as an experimental therapy in PCOS and advises that anyone choosing it should be told about the limited evidence for benefit. Monash University now hosts the guideline under the name polyendocrine metabolic ovarian syndrome (PMOS), a proposed new name for PCOS.

That is the context behind searches pairing Monash with "inositol limited clinical benefits." The guideline does not say inositol is harmful. It says the trials are too small, too short and too varied in their dosing to support a firm recommendation for one form over another.

Who prescribes or recommends inositol for PCOS?

Inositol is sold over the counter as a dietary supplement, so no prescription is needed. The US Food and Drug Administration (FDA) regulates it as a supplement rather than a drug, which means it has not been approved to treat PCOS and products are not reviewed for effectiveness before sale.

The clinicians who most often discuss it are gynecologists, reproductive endocrinologists and fertility specialists, endocrinologists, primary care physicians, registered dietitians, and integrative or functional medicine physicians. Many women use it alongside first-line PCOS care such as lifestyle changes, combined oral contraceptives, metformin, letrozole for ovulation induction, or GLP-1 medications. Our overview of PCOS treatment options compares these approaches, and the post on GLP-1 medications for PCOS covers the newer weight and insulin drugs.

If you want a clinician who works with hormones and metabolic health, the directory of hormone therapy clinics lists practices by state and city, and the hormone replacement therapy guide explains what those clinics typically offer. Regenerated.com is free for patients, listing order is not paid ranking, Featured slots are labeled and capped, and Verified means credential checks rather than spend. Inclusion in the directory is not an endorsement, so ask any practice how it approaches PCOS before booking.

Dosing

The most studied approach is myo-inositol 4 grams per day, usually split into two 2 gram doses taken morning and evening. When D-chiro-inositol is added in the 40:1 ratio, that works out to roughly 4 grams of myo-inositol plus about 100 milligrams of D-chiro-inositol per day. Inositol commonly comes as a powder that dissolves in water, or as capsules.

• Consistency matters. Trials generally ran for three to six months, and benefits such as cycle regularity tend to appear gradually rather than immediately.
• Folic acid is often included. Many PCOS formulations combine inositol with folic acid, which reflects how it was studied, though the folic acid is not the active ingredient driving the metabolic effect.
• More is not better with DCI. Choosing a product with a high proportion of D-chiro-inositol is not supported by the ovulation research.

A single capsule holds far less than the 4 gram daily amount used in trials, so reaching that dose with capsules can mean many capsules a day. That is one reason powder is the common format in the research.

Safety and who should be cautious

Inositol has a strong safety record in the studies done so far. The longest controlled safety data covers about 12 months at 4 grams per day with no concerning findings, and at standard doses side effect rates are often similar to placebo. When side effects do occur they are usually mild and digestive, such as nausea, gas, or stomach upset, and they tend to appear at higher doses (around 12 grams per day or more), where some people also report headache, dizziness, or tiredness.

A few sensible cautions still apply:

• Pregnancy and trying to conceive. Myo-inositol has been studied in pregnancy and is generally well tolerated, but if you are pregnant or actively trying to conceive, confirm your plan with your doctor.
• Medications and other conditions. If you take medication for blood sugar, mood, or other conditions, check with a clinician or pharmacist, since inositol can influence insulin signaling.
• Supplements are not tightly regulated. Quality varies between brands, so look for products that clearly state the form, the ratio, and the dose.
• Not a replacement for prescribed care. If your clinician has prescribed treatment, do not stop or swap it for a supplement without discussing it first.

Third-party testing seals from independent labs can help confirm that a supplement contains what its label says, though they do not show that it works. Watching for signs of insulin resistance and tracking cycle length over several months gives you and your clinician something concrete to review. If acne is one of your main PCOS symptoms, the acne condition page and the post on hormonal acne cover other options to raise at the same visit.

Frequently asked questions

Is inositol the same as myo-inositol?

Mostly, yes. Inositol is the family name for nine related molecules, and myo-inositol is the most common one in food, in the human body and in supplements. A bottle labeled only "inositol" almost always contains myo-inositol. The term to watch for is D-chiro-inositol, a different form that PCOS products add in small amounts, usually in a 40:1 ratio. Inositol hexaphosphate (IP6) is a separate compound and is not the form studied for PCOS.

What is the difference between myo-inositol and D-chiro-inositol?

Myo-inositol is the most abundant form and supports glucose uptake, FSH signaling and egg development in the ovary. D-chiro-inositol is made from myo-inositol by an insulin-dependent enzyme and is more involved in storing glucose as glycogen. In PCOS research, myo-inositol is the main ingredient at about 4 grams per day, while D-chiro-inositol is used only in small amounts, roughly 100 milligrams, because excess DCI may work against egg quality and ovulation.

How long does inositol take to work for PCOS?

Most studies ran for three to six months. Some women notice changes in cycle regularity within a few months, but effects build gradually, so it is reasonable to give it a consistent trial of at least three months before judging whether it helps. Tracking cycle length, and any lab results such as fasting insulin or glucose that your clinician orders, makes it easier to tell whether the supplement is making a difference.

Should I take myo-inositol alone or the 40:1 combination?

Both are used. The 40:1 myo-inositol to D-chiro-inositol combination is the most studied ratio for ovulation, and myo-inositol alone at 4 grams per day also has supportive evidence. What the research consistently discourages is a product heavy in D-chiro-inositol, since excess DCI may work against egg quality. The 2023 International PCOS Guideline did not favor any one form, so the choice is reasonable to make with your clinician.

Is inositol better than metformin?

Several trials suggest the two have broadly similar effects on ovulation and metabolic markers, with inositol often better tolerated and metformin backed by longer clinical use. Neither is clearly superior for everyone, and the right choice depends on your goals, your other health factors, and your clinician’s judgment. Metformin is a prescription drug the 2023 guideline does recommend for some adults with PCOS, while inositol remains an evidence-limited supplement.

Can inositol help me get pregnant?

Some studies link myo-inositol with improved ovulation and pregnancy rates in PCOS, but the evidence is not strong enough to promise a fertility benefit. If conception is your goal, treat inositol as one possible part of a plan you build with a fertility-aware clinician. Letrozole is the first-line medication for ovulation induction in the 2023 guideline, and a reproductive endocrinologist can explain how inositol might fit alongside it.

Related reading

• The complete guide to PCOS
• PCOS and insulin resistance
• Metformin vs inositol for PCOS

This article is for education and is not medical advice. Inositol can interact with how your body handles blood sugar and other medications, so talk with a qualified healthcare professional before starting any supplement, especially if you are pregnant, trying to conceive, or being treated for PCOS or another condition.